Since the long term effect of diabetes include the high risk of cardiovascular diseases, statins (HMG-CoA reductase inhibitor) are a main line of therapy in reducing cardiovascular risk in the patients suffering from type 2 diabetes [38, 39]. The gene discussed is HMGCR; the disease is type 2 diabetes mellitus.